Affimed
AFMD
$5.03
Share price
3.07%
Change (1 day)
458.89%
Change (1 year)
Categories
Affimed (AFMD) - Net assets
Net assets on the balance sheet as of September 2023 : $80.73 M
According to Affimed
's latest financial reports the company has $80.73 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Affimed - Net assets on balance sheet (from 2013 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $0.16 B | 6.37% |
| 2021-12-31 | $0.15 B | 73.87% |
| 2020-12-31 | $88.55 M | 104.43% |
| 2019-12-31 | $43.31 M | -5.64% |
| 2018-12-31 | $45.9 M | 21.09% |
| 2017-12-31 | $37.91 M | -7.07% |
| 2016-12-31 | $40.79 M | -44.54% |
| 2015-12-31 | $73.55 M | 90.22% |
| 2014-12-31 | $38.66 M | -128.22% |
| 2013-12-31 | $-0.14 B | 41.67% |
| 2012-12-31 | $-96.73 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Repligen
RGEN | $1.97 B | 2,341.43% | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | $18.74 M | -76.78% | 🇺🇸 USA |
 Agenus
AGEN | -$0.15 B | -283.78% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $58.95 M | -26.98% | 🇺🇸 USA |